UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                     PURSUANT TO SECTION 13 OR 15(D) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

       Date of Report (Date of earliest event reported): FEBRUARY 28, 2006

                              ALPHA INNOTECH CORP.
             (Exact name of registrant as specified in its charter)

          DELAWARE                    1-14257                    58-1729436
(State or other jurisdiction        (Commission                (IRS Employer
       of incorporation)            File Number)             Identification No.)


          2401 MERCED STREET, SAN LEANDRO, CALIFORNIA              94577
           (Address of principal executive offices)              (Zip Code)

       Registrant's telephone number, including area code: (510) 483-9620

                                       N/A
--------------------------------------------------------------------------------
          (Former name or former address, if changed since last report)

         Check the  appropriate  box below if the Form 8-K filing is intended to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions (SEE General Instruction A.2. below):

         |_|      Written   communications   pursuant  to  Rule  425  under  the
                  Securities Act (17 CFR 230.425)

         |_|      Soliciting material pursuant to Rule 14a-12 under the Exchange
                  Act (17 CFR 240.14a-12)

         |_|      Pre-commencement  communications  pursuant  to  Rule  14d-2(b)
                  under the Exchange Act (17 CFR 240.14d-2(b))

         |_|      Pre-commencement  communications  pursuant  to Rule  13e-4(c))
                  under the Exchange Act (17 CFR 240.13e-4c))





ITEM 5.02         DEPARTURE  OF DIRECTORS  OR  PRINCIPAL  OFFICERS;  ELECTION OF
                  DIRECTORS; APPOINTMENT OF PRINCIPAL OFFICERS.

         On February 28, 2006,  the Board of  Directors  (the  "Board") of Alpha
Innotech Corp. (the "Company") elected John Hodgman as a director of the Company
to serve until the Company's 2006 annual meeting of stockholders  and a chairman
of the Board's Audit Committee.

         Mr.  Hodgman  also  serves on the  boards of a number of  publicly  and
privately held biotechnology and technology companies,  including AVI BioPharma,
Inc., Cygnus,  Inc. (as Chairman),  Inflazyme  Pharmaceuticals (as Chairman) and
Immersion  Corporation.  Mr. Hodgman has had leadership positions in a number of
biotechnology  and  technology  companies.  He  served as  President  and CEO of
Aerogen, Inc. where he directed the merger with Nektar Corporation. From 1994 to
2005 he was with Cygnus,  Inc. serving as Chairman,  President and CEO from 1998
where he lead the  commercialization  of the  first  FDA  approved  non-invasive
continuous  glucose  monitor  system.  Mr. Hodgman also held  corporate  officer
positions with Central Point Software and Ateq Corporation.  In addition, he has
been a consultant for Price  Waterhouse  Consulting  Group. Mr. Hodgman received
his B.S. in Accounting and Finance from Brigham Young  University and his M.B.A.
in Finance and Business Law from the University of Utah.

         As all non-employee  directors of the Company, Mr. Hodgman will receive
an annual cash  retainer of $10,000 and a stock option grant of 10,000 shares of
Common Stock of the Company to vest  monthly  beginning on February 27, 2006 for
so long as he continues to serve on the Board of Directors of the Company, to be
fully vested  February 27, 2007. In addition,  he will receive a cash payment of
$1,000 for  attending  each meeting of the Board of directors in person and $250
for attending each meeting of the Board of Director via teleconference.


                                       2



                                    SIGNATURE

         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  Registrant  has duly  caused  this report to be signed on its behalf by the
undersigned hereunto duly authorized.


                                            ALPHA INNOTECH CORP.



Date:    March 2, 2006                      By:      /S/ HASEEB CHAUDHRY
                                               ---------------------------------
                                                         Haseeb Chaudhry
                                                         Chief Executive Officer


                                       3